Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Tract Infections 1Ureteral Obstruction 1Prostatic Neoplasms 1Neoplasms 1Infections 1Acute Kidney Injury 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Antibiotic Prophylaxis × Clear all
NCT06801405 2026-05-19

Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction

Barretos Cancer Hospital

Completed
320 enrolled 6 charts
Genitourinary

Neoplasms, Ureteral Obstruction, Urinary Tract Infections, Acute Kidney Injury

NCT04843566 2025-04-15

PREVENT

Weill Medical College of Cornell University

Phase NA Completed
687 enrolled 11 charts
Genitourinary

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡